Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Theravance Biopharma (TBPH) Tax Rate (2016 - 2025)

Theravance Biopharma (TBPH) has disclosed Tax Rate for 12 consecutive years, with 16.56% as the latest value for Q4 2025.

  • Quarterly Tax Rate fell 92.0% to 16.56% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 18.11% through Dec 2025, down 56798.0% year-over-year, with the annual reading at 18.1% for FY2025, 56799.0% down from the prior year.
  • Tax Rate for Q4 2025 was 16.56% at Theravance Biopharma, down from 224.99% in the prior quarter.
  • The five-year high for Tax Rate was 224.99% in Q3 2025, with the low at 69.66% in Q4 2023.
  • Average Tax Rate over 5 years is 7.36%, with a median of 0.02% recorded in 2022.
  • The sharpest move saw Tax Rate crashed -6968bps in 2023, then skyrocketed 25131bps in 2025.
  • Over 5 years, Tax Rate stood at 0.35% in 2021, then crashed by -94bps to 0.02% in 2022, then plummeted by -331180bps to 69.66% in 2023, then soared by 125bps to 17.48% in 2024, then decreased by -5bps to 16.56% in 2025.
  • According to Business Quant data, Tax Rate over the past three periods came in at 16.56%, 224.99%, and 25.09% for Q4 2025, Q3 2025, and Q2 2025 respectively.